Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | STAT1 | P42224 | 1/20 | 0.35 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | FYN | P06241 | 1/20 | 0.34 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
| ▸ | AHR | P35869 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL430372 | 0.86 | STAT3 (0.50) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL430371 | 0.85 | STAT3 (0.34) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL226507 | 0.85 | STAT3 (0.48) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL28501396 | 0.84 | STAT3 (0.33) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL28486323 | 0.84 | STAT3 (0.33) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL224501 | 0.84 | — | — | |
| Pyrene SCHEMBL223706 | 0.82 | ALDH1A1 (0.44) | STAT3STAT1ERBB2CYP1A2FYN | |
| Pyrene SCHEMBL27924575 | 0.81 | CYP1A2 (0.42) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL28607985 | 0.79 | CYP1A2 (0.37) | STAT3STAT1ERBB2CYP1A2FYN | |
| SCHEMBL3116089 | 0.76 | CYP1A2 (0.39) | STAT3STAT1ERBB2CYP1A2FYN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10256421-B2 | Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2019-04-09 | — | — | US | disclosed |
| US-20170092883-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2017-03-30 | — | — | US | disclosed |
| US-20150280149-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2015-10-01 | — | — | US | disclosed |
| US-9113535-B2 | Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications | THE UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2015-08-18 | — | — | US | disclosed |
| EP-2590983-A2 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRIC APPLICATIONS | The University Of Southern California (US) | 2013-05-15 | — | — | EP | disclosed |
| WO-2012012117-A2 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRIC APPLICATIONS | The University of Southern California USC Stevens Institute for Innovation (US) | 2012-01-26 | — | — | WO | disclosed |
| US-20120001155-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10256421-B2 | Fusing porphyrins with polycyclic aromatic hydrocarbons and heterocycles for optoelectronic applications | PPOX, HMBS, TYR | STAT3 3947/4885STAT1 3941/4885ERBB2 2511/4885 |
| US-20150280149-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | PPOX, HMBS, TYR | STAT3 3965/4885STAT1 3858/4885ERBB2 2950/4885 |
| US-20120001155-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | PPOX, HMBS, NONO | STAT3 3929/4885STAT1 3896/4885ERBB2 2884/4885 |
| US-20170092883-A1 | FUSING PORPHYRINS WITH POLYCYCLIC AROMATIC HYDROCARBONS AND HETEROCYCLES FOR OPTOELECTRONIC APPLICATIONS | PPOX, HMBS, TYR | STAT3 3965/4885STAT1 3858/4885ERBB2 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.